BR0014548A - Tratamento de endometriose ou de infertilidade, ou melhoramento de fertilidade - Google Patents

Tratamento de endometriose ou de infertilidade, ou melhoramento de fertilidade

Info

Publication number
BR0014548A
BR0014548A BR0014548-3A BR0014548A BR0014548A BR 0014548 A BR0014548 A BR 0014548A BR 0014548 A BR0014548 A BR 0014548A BR 0014548 A BR0014548 A BR 0014548A
Authority
BR
Brazil
Prior art keywords
treatment
endometriosis
infertility
fertility
improvement
Prior art date
Application number
BR0014548-3A
Other languages
English (en)
Portuguese (pt)
Inventor
William J Bologna
Dominique De Ziegler
Howard L Levine
Original Assignee
Columbia Lab Bermuda Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia Lab Bermuda Ltd filed Critical Columbia Lab Bermuda Ltd
Publication of BR0014548A publication Critical patent/BR0014548A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
BR0014548-3A 1999-10-05 2000-10-04 Tratamento de endometriose ou de infertilidade, ou melhoramento de fertilidade BR0014548A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15775499P 1999-10-05 1999-10-05
US66838400A 2000-09-25 2000-09-25
PCT/EP2000/009708 WO2001024788A2 (en) 1999-10-05 2000-10-04 Treating endometriosis or infertility, or improving fertility

Publications (1)

Publication Number Publication Date
BR0014548A true BR0014548A (pt) 2002-06-04

Family

ID=26854456

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0014548-3A BR0014548A (pt) 1999-10-05 2000-10-04 Tratamento de endometriose ou de infertilidade, ou melhoramento de fertilidade

Country Status (28)

Country Link
EP (1) EP1220667B1 (enExample)
JP (2) JP2003510354A (enExample)
KR (1) KR100738724B1 (enExample)
CN (1) CN1218694C (enExample)
AR (1) AR028487A1 (enExample)
AT (1) ATE271860T1 (enExample)
AU (1) AU780736B2 (enExample)
BR (1) BR0014548A (enExample)
CA (1) CA2385974C (enExample)
CO (1) CO5251423A1 (enExample)
DE (1) DE60012554T2 (enExample)
DK (1) DK1220667T3 (enExample)
ES (1) ES2223581T3 (enExample)
GE (1) GEP20043313B (enExample)
HK (1) HK1044120B (enExample)
HU (1) HU225990B1 (enExample)
IL (2) IL148784A0 (enExample)
MA (1) MA25501A1 (enExample)
MX (1) MXPA02003453A (enExample)
MY (1) MY129518A (enExample)
NO (1) NO329663B1 (enExample)
NZ (1) NZ518429A (enExample)
PE (1) PE20010742A1 (enExample)
PT (1) PT1220667E (enExample)
TR (1) TR200200899T2 (enExample)
TW (1) TWI280877B (enExample)
UA (1) UA74168C2 (enExample)
WO (1) WO2001024788A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101327326A (zh) * 2001-10-29 2008-12-24 哥伦比亚实验室(百慕大群岛)有限公司 阴道给药治疗骨盆痛和不孕症的抗节律障碍剂
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
ES2237298B1 (es) 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
EP1872775A1 (en) 2006-06-29 2008-01-02 Polichem S.A. Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant for the manufacture of a medicament for treating female genital disorders
ES2344673B1 (es) 2008-08-07 2011-05-03 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farmaceutica parael tratamiento de atrofia vaginal en mujeres con riesgo de potologiatumoral.
ES2344675B1 (es) 2008-12-19 2011-04-28 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farrmaceutica para el tratamiento de atrofia vaginal en mujeres con riesgo de patologiacardiovascular.
CN107260745A (zh) * 2010-03-22 2017-10-20 利普生物药剂公司 用于抗孕酮的非毒性递送的组合物和方法
KR101010031B1 (ko) * 2010-12-08 2011-01-21 류상범 흡수식 냉온수기용 엘리미네이터
US10328022B2 (en) 2012-05-31 2019-06-25 Repros Therapeutics Inc. Formulations and methods for vaginal delivery of antiprogestins
HK1211852A1 (en) 2012-11-02 2016-06-03 Repros Therapeutics Inc. Methods and compositions for treating progesterone-dependent conditions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241087A (en) * 1979-04-02 1980-12-23 William H. Rorer, Inc. Dysmenorrhea treatment
AU5068090A (en) * 1989-03-07 1990-09-13 Adeza Biomedical Corporation Endometriosis diagnosis methods and reagents
JP2602456B2 (ja) * 1990-04-12 1997-04-23 雪印乳業株式会社 子宮内膜症治療剤
IT1251114B (it) * 1991-07-26 1995-05-04 Farcon Ag Forme farmaceutiche antivirali per applicazione vaginale
DE69819748T2 (de) * 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen

Also Published As

Publication number Publication date
NZ518429A (en) 2004-02-27
CA2385974A1 (en) 2001-04-12
WO2001024788A3 (en) 2001-12-06
NO329663B1 (no) 2010-11-29
AU7525000A (en) 2001-05-10
JP2010018639A (ja) 2010-01-28
EP1220667A2 (en) 2002-07-10
ES2223581T3 (es) 2005-03-01
PT1220667E (pt) 2004-11-30
ATE271860T1 (de) 2004-08-15
CN1218694C (zh) 2005-09-14
UA74168C2 (uk) 2005-11-15
JP2003510354A (ja) 2003-03-18
DK1220667T3 (da) 2004-12-06
MY129518A (en) 2007-04-30
DE60012554D1 (de) 2004-09-02
TWI280877B (en) 2007-05-11
HUP0203050A3 (en) 2006-02-28
AU780736B2 (en) 2005-04-14
DE60012554T2 (de) 2005-11-24
CA2385974C (en) 2010-01-26
GEP20043313B (en) 2004-03-10
IL148784A0 (en) 2002-09-12
TR200200899T2 (tr) 2002-07-22
AR028487A1 (es) 2003-05-14
HU225990B1 (en) 2008-02-28
IL148784A (en) 2006-12-31
CO5251423A1 (es) 2003-02-28
KR100738724B1 (ko) 2007-07-12
NO20021591L (no) 2002-05-28
EP1220667B1 (en) 2004-07-28
CN1377264A (zh) 2002-10-30
PE20010742A1 (es) 2001-07-19
MA25501A1 (fr) 2002-07-01
KR20020062285A (ko) 2002-07-25
HK1044120B (en) 2004-12-17
NO20021591D0 (no) 2002-04-04
WO2001024788A2 (en) 2001-04-12
MXPA02003453A (es) 2002-08-20
HUP0203050A2 (hu) 2003-02-28
HK1044120A1 (en) 2002-10-11

Similar Documents

Publication Publication Date Title
BR0014548A (pt) Tratamento de endometriose ou de infertilidade, ou melhoramento de fertilidade
BR9914901A (pt) Agonistas do receptor 5ht1 e metoclopramida para o tratamento de enxaqueca
BRPI9913945B8 (pt) Composição farmacêutica rapidamente atuante para a administração sublingual de um agente farmacêutico para o tratamento de distúrbios agudos
UY25794A1 (es) Procedimiento para la preparacion de compuestos derivados de adeninas, que son agonistas del receptor de la adenosina a2a
ES2180626T3 (es) Composiciones que comprenden un agente bloqueante de la desgranulacion de celulas cebadas para el tratamiento de estados gastrointestinales dolorosos endogenos de origen no inflamatorio y no ulcerativo.
AR020442A1 (es) Agonistas de 5ht2serotonergicos para el tratamiento de glaucoma
BR9710768A (pt) Composto composi-Æo e processos para tratamento de infec-{es bacterianas em um mamifero hospedeiro com necessidade de tal tratamento e para prepara-Æo de 6-0-metileritromicina forma i
WO2000008015A3 (en) Fsh mimetics for the treatment of infertility
BR9813973A (pt) Composto, processo para prepará-lo, uso do mesmo, composição farmacêutica, e, processo para o tratamento de um paciente sofrendo de uma condição.
FI954944A0 (fi) Indolijohdannaisia 5-HT1-kaltaisina agonisteina käytettäväksi migreenin hoitoon
BR9810706A (pt) Processo para a prevenção ou tratamento do prurido em um mamìfero em necessidade de tal prevenção ou tratamento
BR0111196A (pt) Composições e uso das mesmas para tratamento de flavivìrus e pestivìrus
BR0206492A (pt) Composição farmacêutica para inibir a replicação de um vìrus dentro de células, uso de pelo menos um agonista receptor de adenosina a3, e, métodos para inibir a replicação de um vìrus em células
MXPA01009552A (es) Metodo para proteger, preservar e interrumpir el funcionamiento de un organo.
BR9915818A (pt) Processo e composições para a prevenção de tolerância a medicações
ES2193391T3 (es) Antagonistas muscarinicos.
BR9908857A (pt) Métodos e composições para tratamento, inibição e prevenção de mucosite
AU3419995A (en) Combination of an opioid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholism and alcohol dependence
BR9813684A (pt) Processo para tratar o glaucoma glc1a, e, composição para controlar o glaucoma glc1a.
BR0115952A (pt) Composição de emulsão para administração terapêutica, método de administração, processo para o preparo de uma formulação contendo derivados de fosfato de agentes de transferência de elétrons
DE60336509D1 (de) Zubereitungen enthaltend sincalide
BR9908510A (pt) Uso de um composto, composto, processo para a preparação de um composto, composição farmacêutica, e, processo de tratar um paciente que sofre de, ou em risco de, uma doença micobacteriana
BR0008297A (pt) Uso de 4,6-o-(benzilideno-d1) -d-glucopiranose, 4,6-o-benzilideno-l-glucopiranose, e/ou 4,6-o-(benzilideno-d1) -l-glucopiranose, ou um sal farmacêutico aceitável dos mesmos, derivado de benzaldeìdo composição farmacêutica, e, processo para a fabricação da mesma
SE9603725D0 (sv) New teatment
BR0201524A (pt) Tratamento de combinação para ansiedade e depressão

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 13, 24, 25 DA LPI

B12B Appeal against refusal [chapter 12.2 patent gazette]